Nanovery

Nanovery is developing nanorobots to diagnose the world’s deadliest diseases.

The world spends $4 trillion on chronic diseases annually, of which $1.2 trillion is on cancer.

Recent advances enabled early cancer detection with just a blood sample. But this still takes 2 weeks.

Nanovery develops nanorobots for early disease detection in 2 hours. They are starting with cancer but rolling out to other diseases. Their nanorobots can be dropped into blood samples and they light up when they capture a disease biomarker.

They are in discussions with several pharma companies, have confirmed collaboration with Genomics England and are partnering in a number of clinical trials.